deformity is minimal, if present at all, and lung function (as assessed by peak flow or spirometry on routine visits to the clinic or surgery) is usually normal. Many will respond entirely satisfactorily to treatment with oral beta-2 stimulants.2 Regular treatment with sodium cromoglycate or theophylline is not indicated-and if prescribed is unlikely to be taken in the long term. Alternatively, these children can be helped by taking inhaled bronchodilator drugs as soon as symptoms begin, either in the form of salbutamol Rotohaler3 or, in those over the age of 7 and sufficiently well co-ordinated, one of the beta-2 pressurised aerosols. The chances of any of these children becoming critically ill are remote, and most will either grow out of their symptoms by puberty or show considerable improvement.
The remaining asthmatic children are more worrying-but they form less than 1%1 ofthe child population. These children have frequent troublesome attacks which interfere with their social and educational life. Indeed, if not adequately treated the disease will tend to isolate the child. Nevertheless, many such children have periods when they are asymptomatic and are apparently entirely well. These patients, who are categorised as group C,1 again should have no growth retardation but they may have some chest deformity with bilateral Harrison's sulci-particularly at the younger end of the age range. Lung function tests will show wide variation ranging from normality to severe airways obstruction. Some of these children may have severe life-threatening attacks, and all require regular maintenance treatment. Usually beta-2-stimulant drugs are insufficient. The alternatives are oral theophylline, using a slow-release preparation which can be given every eight to 12 hours,4 or thrice-daily sodium cromoglycate given by Spinhaler.
© BRITISH MEDICAL JOURNAL 1982. All reproduction rights reserved.
The combination of either of these two regimens with inhaled beta-2-stimulant drugs at times when symptoms break through can alter the child's capability dramatically.5 Some continue to have severe breakthrough wheezing attacks, indicating that both sodium cromoglycate and theophylline are more likely to relieve mild to moderate bronchoconstriction than the severe episodes.6 If these severe attacks are infrequent the child can usually be nursed through with the help of nebulised beta-2-stimulant solutions-for example, salbutamol every four to six hours.7 This is available in all children's accident and emergency departments, and many general practitioners are now equipping health centres and surgeries with compressor systems which may if necessary be taken to the child's home. If the response to salbutamol is inadequate the child will require systemic steroids or even admission to hospital depending on previous history, the severity of the attack, and social circumstances. If the child has had more than one attack within a few months the theophylline or sodium cromoglycate should be replaced by inhaled topical steroid treatment.8 9 The parents may also be given packs of courses of steroids so that these may be started when the child's condition begins to deteriorate.
The remaining children are undoubtedly the most worrying of all-but fortunately the least common. These children have chronic symptoms of asthma which fluctuate in severity. Some will have had their growth retarded and all are likely to have chest deformity and evidence of hyperinflation. Often there is little abnormal to hear on auscultation, but the peak flow will almost always be reduced, often by more than half. These children are categorised as group D.' Asthma of this severity is unlikely to be helped to any great extent by either sodium cromoglycate or by theophylline treatment, though these may be worth trying over one to three months. Almost all will require topical steroids with regular inhaled beta-2-stimulants. Severe attacks will require nebulised salbutamol and courses of systemic steroids. If these episodes occur frequently it will be worth providing the faAmily with a nebuliser for use at home on a regular or intermittent basis. Steroids given on alternate days should be considered if the child continues to require intermittent high-dose courses, as this form of administration has less effect on growth than daily treatment.10
All these high-risk children-and their parents-must be carefully instructed on the signs that the asthma is slipping VOLUME 285 NO 6336 PAGE 155 out of control. Breathlessness, coughing, and wheezing are difficult to quantify, and with poor lighting a considerable degree of cyanosis may be missed. Guidelines should instead be based on response to treatment, instructing the parents to seek immediate medical advice if the child fails to obtain satisfactory relief from his beta-2-stimulant treatment, or even if the response to treatment falls off after one or two hours. These recommendations are particularly important if the child has a nebuliser at home or is taking regular systemic steroids, as response to any additional treatment is likely to be slow.
Some children have asthma which is particularly difficult to categorise. The parents may complain bitterly about the child's symptoms which are apparently totally isolating him from his friends and preventing him from attending school, yet on assessment in the clinic he looks remarkably well and has an entirely normal peak flow. A careful history and measurement of peak flow twice daily at home over one to two weeks may show that the child's asthma is, in fact, relatively mild, suggesting other parental anxieties in the home which may need sorting out.
At the other end of the spectrum are the more worrying children who complain little, cope well with school and often games, and yet on examination are obviously undersized with hyperinflated chests-but often with little abnormal heard on auscultation. Their peak flows, however, are strikingly reduced, often to less than one-third of expected. Response to inhaled beta-2-stimulants is usually poor. These children need careful evaluation since they are chronically hypoxic and have very little respiratory reserve. They are particularly likely to die in the night if a further severe attack is superimposed on their chronic state.11 Virtually normal lung function can usually be achieved by giving them a 14-21-day course of prednisolone using 1-2 mg/kg a day.12 This will confirm the diagnosis of asthma and also reset the child's expectation of life. It will also allow the doctor to reconsider his therapeutic attack.
Undoubtedly the number of deaths from asthma in childhood may be reduced provided the severity of the disease is assessed correctly and appropriate treatment given. A few children, sadly, will die whatever action we take. An example of this is provided by a Nottingham girl who wheezed intermittently up to the age of 12 
Causes of intrauterine growth retardation
When a baby is fmrall for -gectational age at birth, a specific cause for the failure of owth can be identified in only a minority of cases. If the baby has a congenital abnormality,' or a viral infection such as rubella2 or cytomegalovirus,3 these may be recognised as specific causes. In most such cases, however, no single cause can be identified and the failure of growth is due to a number of factors, each making its contribution to the end result. Physiological factors influence fetal growth, and normal genetic influences contribute to birth weight variation.4 Boys are bigger than girls, first-born infants are smaller than later born,5 and mean birth weights vary among different races. What is important is that every baby should achieve its own optimal potential for intrauterine growth and development. Because intrauterine growth retardation is a syndrome of starvation and is commoner in lower social-class groups,6 maternal malnutrition is often assumed to be an important cause of small size for gestational age. The evidence to support this, however, is unconvincing. Though babies born in Holland under severe famine conditions between 1944 and 1945 were 300-400 g below expected birth weight, the reduction in birth weight was not apparent until maternal food intake fell below 6-3 MJ (1500 kcal) a day. Once energy intakes fell below the threshold level to maintain birth weight the reduction in fetal length was less than the reduction in fetal weight, and the subsequent development of the babies was normal.7 This suggested that, though subcutaneous fat was reduced, the development of vital organs had been normal. There have been several trials to investigate the value of prenatal dietary supplements and, though their study designs have been criticised, their results have consistently shown that dietary supplements have only a trivial effect on birth weight.8 Indeed, high protein diets may reduce birth weight, possibly by reducing the maternal intake of fat and carbohydrate.9 On the other hand, mothers of short stature or low weight before pregnancy, who may have chronic suboptimal nutrition, have an increased risk of a baby small for gestational age.6 Possibly to be effective dietary supplementation would be required for months, or even years, before the pregnancy was started.
The ability of the mother to transfer nutrients across the placenta is as important as the concentration ofthe nutrients in the maternal circulation.10 Anatomical abnormalities of the placenta are often found in association with small-for-gestational-age pregnancies, but,-apart from conditions such as extrachorial placenta or rare vascular tumours, the placental changes are usually secondary to defective uteroplacental blood flow.1' In small-for-gestational-age pregnancies associated with proteinuric pre-eclampsia the uteroplacental vessels are occluded by thrombotic and atheromatous lesions.'2 Similarly,
